eLetters

218 e-Letters

published between 2004 and 2007

  • Author's reply
    Josefin Nilsson
    Dear Editor,

    In a reply to my editorial in the November issue, Dr Lempert raises several valid concerns regarding vision screening for amblyopia. I would like to thank Dr Lempert for his reply and this possibility for a discussion on a difficult and important topic!

    I was, however, slightly surprised to find that the reply is written as a rebuttal of my arguments, while I am of the same opinion as Dr Lempert, and have...

    Show More
  • Ethnic variation in incidence of giant cell arteritis
    Ameet Shah

    Dear Editor

    We read with interest the editorial by Miller which comments on the paper, ‘Epidemiology of giant-cell arteritis in an Arab population: a 22-year study’[1]. The author of the editorial comments on geographical variation in the incidence of giant cell arteritis and cites evidence supporting both genetic and environmental aetiologies.

    We re-examined the data from our 5 year study[2] looking at...

    Show More
  • Ocular blood flow and glaucoma
    Antonio Martinez

    Dear Editor:

    We read with great interest the recent commentary by Stewart et al [1] describing the evidence of the blood flow disturbances in the pathogenesis of the glaucomatous damage. Although I agree with some of the findings of this excellent review, there are some important points that should be addressed:
    1.After reading this article, one may think that there is not evidence that ocular bl...

    Show More
  • Frequency of Purtscher's retinopathy
    Gabor Holló

    Dear Editor,

    In their article Doctors Agrawal and McKibbin evaluate the one-year frequency and the clinical outcome data of Putscher’s retinopathy through the British Ophthalmological Surveillance Unit. [1] All their 15 cases were visually symptomatic. Twelve cases were associated with trauma and 3 cases with acute pancreatitis. The authors conclude that the incidence of Purtsher’s retinopathy is low (0.24 case...

    Show More
  • Amblyopia and visual function
    Philip Lempert

    Re: van Leeuwen R, Eijkemans MJC, Vingerling JR, Hofman A, de Jong PTVM, Simonsz HJ Risk of bilateral visual impairment in individuals with amblyopia: the Rotterdam study BJO 2007;91 (11): 1450

    Josefin Nilsson The negative impact of amblyopia from a population perspective: untreated amblyopia almost doubles the lifetime risk of bilateral visual impairment. BJO 2007;91 (11): 1417

    Dear Editor

    ...

    Show More
  • We are part of the problem
    Andrew Bastawrous

    Dear Editor

    We read with great interest the report by Raftery et al on Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectiveness. The authors raise the very pertinent point in respect to a single company owning two competing drugs and the inherent cost to tax payers. The authors conclude their abstract with "Public pressure may be the most potent weapon in persuading Genentech to license bevaciz...

    Show More
  • Bevicizumab detection
    Rajesh K Sharma

    Dear Editor,

    We appreciated the paper by Iriyama et al.[1] The authors have investigated the role of anti vascular endothelial growth factor (VEGF) antibodies on retinal ganglion cells in rats. It is an interesting and relevant paper considering the clinical use of anti-VEGF antibodies in a variety of ocular conditions.[2] However, there are a couple of issues that require further clarification.

    The author...

    Show More
  • Sudden lowering of IOP may cause posterior segment bleeding by three different mechanisms
    Atul Bansal

    Dear Editor,

    We read with great interest the report by Alwitry et al [1] on severe decompression retinopathy after medical treatment of acute angle closure. The authors have speculated that the mechanism of the ‘preretinal’ haemorrhage in this case was similar to the scattered ‘intraretinal’ haemorrhages seen in ocular decompression retinopathy. Although we agree with them that the haemorrhage was caused by sudd...

    Show More
  • Natural killer T cells in chronic uveitis
    Jae Kyoun Ahn

    Dear Editor

    I read with interest the article by Pedroza-Seres M and associates who assessed the pathogenic roles of peripheral CD57+ natural killer T (NKT) cell in pars planitis.[1] The authors compared the frequencies of CD57+ NKT cell in peripheral blood between pars planitis patients and healthy controls, and then evaluated the effector-related surface molecules and functions of CD57+ NKT cells derived from pa...

    Show More
  • Treatment of peripapillary choroidal neovascularisation
    Laurence POSTELMANS

    Dear Editor

    We read with interest the article by Aisenbrey et al [1] who have described the results of surgical treatment of peripapillary choroidal neovascularisation in eight patients.

    As reported, peripapillary choroidal neovascularisation is a relatively uncommon entity that can be a variant of macular choroidal neovascularisation in elderly patients. Accordingly to the MPSG[2], early small peripapilla...

    Show More

Pages